RAMSEY, N.J. (AP) _ Adma Biologics Inc. (ADMA) on Friday reported a loss of $14.7 million in its second quarter.
On a per-share basis, the Ramsey, New Jersey-based company said it had a loss of 35 cents.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.
The infectious disease drug developer posted revenue of $4.7 million in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks expected $5.4 million.
Adma Biologics shares have increased 96 percent since the beginning of the year. The stock has more than doubled in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA